Speedway Motorsports Inc

19.78

0.0000

成交量：- -

成交額：- -

市值：8.08億

市盈率：21.28

高：19.78

開：19.78

低：19.78

收：19.78

52周最高：19.90

52周最低：13.47

股本：4,085.39萬

流通股本：1,124.32萬

量比：- -

換手率：- -

股息：0.60

股息率：3.03%

每股收益(TTM):0.9294

每股收益(LYR):0.9887

淨資產收益率：4.03%

總資產收益率：2.83%

市淨率：0.85

市盈率(LYR):20.01

資料載入中...

總覽公司新聞資訊公告

諾誠健華第二代泛TRK抑制劑ICP-723完成首例青少年患者給藥

美通社

·

2022/10/31

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TRK/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"TRK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRK\",,,,,undefined,":{"symbol":"TRK","market":"US","secType":"STK","nameCN":"Speedway Motorsports Inc","latestPrice":19.78,"timestamp":1569009600000,"preClose":19.78,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":11243173,"shares":40853902,"eps":0.929399,"marketStatus":"交易中","change":0,"latestTime":"03-23 12:22:55 EDT","open":19.78,"high":19.78,"low":19.78,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.929399,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":793515600000,"exchange":"NYSE","adjPreClose":19.78,"dividendRate":0.030334,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRK\",,,,,undefined,":{"symbol":"TRK","floatShares":11243173,"roa":"2.83%","roe":"4.03%","lyrEps":0.988731,"shares":40853902,"dividePrice":0.6,"high":19.78,"amplitude":0,"preClose":19.78,"low":19.78,"week52Low":13.47,"pbRate":"0.85","week52High":19.9,"institutionHeld":0.2191,"latestPrice":19.78,"eps":0.929399,"divideRate":0.030334,"volume":0,"delay":0,"ttmEps":0.929399,"open":19.78,"prevYearClose":19.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-08-14","symbol":"TRK","amount":0.15,"name":"Speedway Motorsports Inc","payableDate":"2019-08-15","currency":"USD","type":"dividend","dateTimestamp":1565755200000},{"market":"US","date":"2019-07-31","symbol":"TRK","fiscalQuarterEnding":"2019/06","expectedEps":0.47,"name":null,"time":"盤前","type":"earning","dateTimestamp":1564545600000,"reportTimeType":"pre","actualEps":0.75},{"market":"US","date":"2019-05-14","symbol":"TRK","amount":0.15,"name":"Speedway Motorsports Inc","payableDate":"2019-05-15","currency":"USD","type":"dividend","dateTimestamp":1557806400000},{"market":"US","date":"2019-05-01","symbol":"TRK","fiscalQuarterEnding":"2019/03","expectedEps":-0.07,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556683200000,"reportTimeType":"pre","actualEps":0.22},{"market":"US","date":"2019-03-13","symbol":"TRK","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1552449600000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRK\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-27","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-08-11","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-11-09","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2018-02-28","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRK\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRK\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2279765208","title":"諾誠健華第二代泛TRK抑制劑ICP-723完成首例青少年患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2279765208","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2279765208?lang=zh_tw&edition=fundamental","pubTime":"2022-10-31 11:23","pubTimestamp":1667186580,"startTime":"0","endTime":"0","summary":"北京2022年10月31日 /美通社/ -- 生物医药高科技公司诺诚健华今天宣布，公司自主研发的第二代泛TRK小分子抑制剂ICP-723在中山大学肿瘤防治中心儿童肿瘤科完成首例青少年患者给药，这也是ICP-723在成人患者中显示良好安全性和有效性后，首次在青少年患者中开展临床研究。诺诚健华也已经在美国进行ICP-723的临床研究，目前在第一个剂量组尚未观察到剂量限制性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3919319_ZH19319_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","BK0239","TRK","09969","ICP","BK1161","688428"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}